Volitionrx (VNRX) Operating Leases (2019 - 2025)
Volitionrx (VNRX) posted Operating Leases of $276558.0 for Q4 2025, down 21.26% on a QoQ basis from $351211.0 in Q3 2025, and down 32.66% year-over-year from $410686.0 in Q4 2024.
Volitionrx (VNRX) Operating Leases (2019 - 2025) Analysis & Trends
Volitionrx's Operating Leases history runs 7 years deep, the most recent figure standing at $276558.0 for Q4 2025.
- Quarterly Operating Leases fell 32.66% year-over-year to $276558.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $276558.0 (down 32.66% YoY) and the FY2025 annual result came in at $276558.0, down 32.66% from the prior year.
- Operating Leases was $276558.0 for Q4 2025 at Volitionrx, down from $351211.0 in the prior quarter.
- Across five years, Operating Leases topped out at $843443.0 in Q1 2022 and bottomed at $143998.0 in Q3 2021.
- A 5-year average of $378095.9 and a median of $378054.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases soared 212.78% — and 2023, when it sank 54.74%.
- Volitionrx's Operating Leases stood at $217305.0 in 2021, then jumped by 84.11% to $400091.0 in 2022, then retreated by 5.51% to $378054.0 in 2023, then increased by 8.63% to $410686.0 in 2024, then tumbled by 32.66% to $276558.0 in 2025.
- Business Quant data shows VNRX's Operating Leases at $276558.0 in Q4 2025, $351211.0 in Q3 2025, and $417015.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 276,558.00 |
| Sep 30, 2025 | 351,211.00 |
| Jun 30, 2025 | 417,015.00 |
| Mar 31, 2025 | 369,342.00 |
| Dec 31, 2024 | 410,686.00 |
| Sep 30, 2024 | 448,045.00 |
| Jun 30, 2024 | 350,810.00 |
| Mar 31, 2024 | 396,376.00 |
| Dec 31, 2023 | 378,054.00 |
| Sep 30, 2023 | 323,957.00 |
| Jun 30, 2023 | 340,314.00 |
| Mar 31, 2023 | 381,722.00 |
| Dec 31, 2022 | 400,091.00 |
| Sep 30, 2022 | 449,326.00 |
| Jun 30, 2022 | 519,485.00 |
| Mar 31, 2022 | 843,443.00 |
| Dec 31, 2021 | 217,305.00 |
| Sep 30, 2021 | 143,998.00 |
| Jun 30, 2021 | 166,085.00 |
| Dec 31, 2020 | 179,624.00 |